News

BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) today announced that the Phase 3 PEGASUS trial evaluating PALYNZIQ® (pegvaliase-pqpz) met its primary efficacy endpoint, demonstrating a statistically ...
In a report released on April 4, Conor O’Prey from Canaccord Genuity maintained a Buy rating on Enero Group Limited (PKU – Research Report), ...
For 15 years, Kuhlow, a 51-year-old former Stony Brook microbiology researcher, has been logging observations of leaf and bud appearances — in his own garden, or farther afield on a hike — into a ...
Pharmaceutical announced that the Phase 3 PEGASUS trial evaluating Palynziq met its primary efficacy endpoint, demonstrating a ...
Sjögren's syndrome is a chronic autoimmune disorder that affects millions worldwide, especially women, causing unrelenting dryness of the mouth and eyes.
PKU is a genetic disease that manifests at birth and results from an inability to break down phenylalanine (phe), an amino acid that is commonly found in many foods. Left untreated, high levels of ...
The research group led by Prof. Wang Chu from the College of Chemistry and Molecular Engineering at Peking University published a research article entitled "Quantitative Chemoproteomics Reveals ...
Among the most vital tests is screening for phenylketonuria (PKU), a rare metabolic disorder that, if undiagnosed, may result in irreversible intellectual disability. Similarly, hypothyroidism—another ...
Laila Maidan is a Tech and Investing reporter at MarketWatch. She covers the rapid developments in the sector along with actionable investment recommendations and deep dives into valuations.
In today’s competitive world, prioritising happiness amid a hectic work schedule and daily life hustle is essential for overall well-being and productivity. A recent example highlighting the ...
Are you brave enough to dive into the world of marine microbes? Get ready to explore the hidden world of these tiny… Science Festival: Discover the secrets of the sea on board the R/V Skagerak! Are ...